Vertigo Research HQ
Editorial Standards
These standards govern topic selection, research, writing, review, commercial eligibility, corrections, and publication at Vertigo Research HQ.
Our two topic gates
Every proposed article must first pass both gates:
- It must be exceptionally useful to the visitor.
- It must serve a visitor who is at or near a meaningful decision point.
Useful but commercially remote topics do not enter this pilot. Commercially close topics that would be thin, manipulative, repetitive, or unsafe do not enter it either.
Research before drafting
We do not begin with a headline and search for support afterward. Before drafting, the article package must establish the audience decision, search and information gap, source plan, evidence boundaries, clinical and regulatory risks, and any commercial relevance.
Primary and authoritative sources are preferred for medical, regulatory, product, and policy claims. A source must support the exact claim made; an ingredient study cannot establish that a finished product works, and evidence for one cause of dizziness cannot be generalized to every cause.
See the full research and comparison methodology.
Claim-level accountability
Every material factual statement must be supported, carefully qualified, or removed. Editors reconcile the final article against its source record rather than relying on a general bibliography.
We distinguish among:
- what a source directly demonstrates;
- what may reasonably be inferred;
- what remains uncertain or unstudied; and
- what a seller merely claims.
We do not use testimonials, popularity, search rank, or affiliate performance as proof of safety or effectiveness.
Medical and safety review
Pages that materially discuss diagnosis, treatment, dosage, interactions, prognosis, clinical interpretation, or medical red flags require qualified medical review before publication.
We name a reviewer and display credentials only after a real review is complete and recorded. Medical review does not replace evidence, regulatory, commercial, editorial, accessibility, or technical review. Read the medical review policy.
Supplement and advertising standards
Supplement content must separate structure or function language from claims that a product diagnoses, treats, cures, or prevents a disease. It must also separate evidence about an ingredient and dose from evidence about the finished formula.
Pages that evaluate a product or seller examine the available label, dose, safety information, testing evidence, seller identity, purchase terms, and refund language. Missing information is reported as missing rather than filled with assumptions.
Commercial independence
Commercial eligibility is decided editorially for the specific page and offer. An experiment cannot make an ineligible page commercial, and article copy never hardcodes a merchant.
Compensation does not change our evidence standard, safety language, inclusion criteria, or conclusions. Affiliate relationships are disclosed both site-wide and near eligible referral actions. Read the affiliate disclosure.
Publication controls
We keep a research record and review package for each article. Drafts remain noindex, stay out of the sitemap, and cannot show a referral until all applicable gates pass and publication is explicitly authorized.
Before authorization, applicable checks include content completeness, citations, disclosure, metadata, internal links, responsive layout, keyboard access, and browser behavior. Routine content changes use fast automated checks; shared template or platform changes receive broader browser and accessibility testing.
Dates, updates, and corrections
Articles show publication or review information when they are authorized. Material changes must be checked against the source record and the same applicable review lanes. We correct material errors and disclosure failures under our corrections policy.
Reader feedback
Questions about these standards, a source, or a possible error can be sent to [email protected]. Please include the page address and the exact statement at issue.